4
Changes in Ownership
Adicet Bio, Inc. Filed Acc 0001209191-23-046103
Options or other derivatives
- President & CEO acquired 2,250,468 shares (grant or award)
- President & CEO returned 2,250,468 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Schor Chen · President & CEO
Table II: Derivative
12 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-14 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −36,857 | 0 | D |
| 2023-08-14 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +36,857 | 36,857 | D |
| 2023-08-14 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −872,111 | 0 | D |
| 2023-08-14 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +872,111 | 872,111 | D |
| 2023-08-14 | Returned to the company : show line 5 in the form Stock Option (Right to Buy) | −240,000 | 0 | D |
| 2023-08-14 | Grant or award : show line 6 in the form Stock Option (Right to Buy) | +240,000 | 240,000 | D |
| 2023-08-14 | Returned to the company : show line 7 in the form Stock Option (Right to Buy) | −421,600 | 0 | D |
| 2023-08-14 | Grant or award : show line 8 in the form Stock Option (Right to Buy) | +421,600 | 421,600 | D |
Loading xslF345X05/doc4.xml…